- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05368883
Comparison of the Effects of One-Legged and Two-Legged Exercise Training on Exercise Capacity and Fatigue in Patients With Sarcoidosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34320
- Istanbul University Cerrahpasa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- According to chest X-ray findings, the severity of the disease is to be stage 2,3,4
- Reaching a score of ≥ 22 on the fatigue assessment scale
- To be clinically stable.
- No change in medical treatment.
Exclusion Criteria:
- Having an orthopedic, neurological, cardiac, or metabolic condition that may prevent participation and continuation of the exercise program throughout the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: One-legged cycling ergometer training
One-legged cycling ergometer training; 10 minutes for each leg in the first 2 weeks, 15 minutes of cycling training in the following weeks.
|
One-legged cycling ergometer training will consist of 5 minutes of warm-up, 10 minutes for each leg in the first 2 weeks, 15 minutes of cycling training in the following weeks (5-10 minutes of rest while switching from one leg to the other leg) and a 5 minutes cool-down period. In the one-legged cycling ergometer training, it will be determined randomly that the patients start the exercise with the dominant or non-dominant leg. One-legged and two-legged exercise training will be maintained at moderate intensity (64-76%) according to maximum heart rate. Both groups will be given walking on flat ground once a week, with an exercise intensity of 11-13 according to the Borg scale, as home exercise. |
Active Comparator: Two-legged cycling ergometer training
Two-legged cycling ergometer training; 20 minutes for the first 2 weeks, 30 minutes of cycling training in the following weeks.
|
Two-legged cycling ergometer training will consist of 5 minutes of warm-up, 20 minutes for the first 2 weeks, 30 minutes of cycling training in the following weeks, and a 5 minutes cool-down period. One-legged and two-legged exercise training will be maintained at moderate intensity (64-76%) according to maximum heart rate. Both groups will be given walking on flat ground once a week, with an exercise intensity of 11-13 according to the Borg scale, as home exercise. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Six-Minute Walking Test Distance from baseline to 8 weeks
Time Frame: 8 weeks
|
The distance covered in meters in a straight corridor of 30 meters will be recorded as fast as possible but without running for 6 minutes.
The distance that normal individuals should take in this period is 400-700 meters.
In addition, oxygen saturation and heart rate, resting fatigue and dyspnea levels will be evaluated with pulse oximetry before and after testing.
Modified Borg Dyspnea and Fatigue Scales will be used to determine resting dyspnea and fatigue levels.
|
8 weeks
|
Change of Endurance Shuttle Walking Test Distance from baseline to 8 weeks
Time Frame: 8 weeks
|
Endurance Shuttle Walk test: This is a standardized field test for the assessment of endurance capacity.
In the Endurance Shuttle Walk Test, the participant walks at a constant speed between cones spaced 10 m apart.
The selected speed is 85% of the participant's maximum capacity measured in the shuttle walk test at increasing speed.
Therefore, before this test, the patient should be given an increasing speed ıncremental shuttle walk test.
|
8 weeks
|
Incremental Shuttle Walk Test
Time Frame: 8 weeks
|
The incremental shuttle walk test (ISWT) is a field-based assessment of cardiorespiratory fitness and physical function.
The ISWT is a performance-based assessment of exercise and functional capacity that measures walking distance in meters.
It is a relatively brief and easy test to perform.
The ISWT simulates a maximal cardiopulmonary test in a field setting and requires minimal equipment.
Longer walking distances signify better performance.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Fatigue Assessment Scale results from baseline to 8 weeks
Time Frame: 8 weeks
|
Fatigue Assessment Scale: It was planned to use Fatigue Assessment Scale to evaluate subjective fatigue.
The Fatigue Assessment Scale is a subjective fatigue questionnaire consisting of 10 items.
It includes five-point Likert type options (1=Always-5=Never).
Higher scores indicate greater levels of fatigue.
|
8 weeks
|
Change of Multidimensional Fatigue Inventory results from baseline to 8 weeks
Time Frame: 8 weeks
|
Multidimensional Fatigue Inventory: It is used for the multidimensional evaluation of fatigue.
It contains 20 questions containing different dimensions of fatigue.
It consists of 5-point Likert-type questions.
High scores indicate high fatigue.
|
8 weeks
|
Change of Blood Lactate Level from baseline to 8 weeks
Time Frame: 8 weeks
|
Blood Lactate Level: Blood lactate level measurements, which are an objective outcome measure in the evaluation of fatigue, will be made, in the 1st week and 8th week, before the exercise, immediately after the exercise, at the 5th minute after the exercise, and at the 20th minute after the exercise.
|
8 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyspnoea
Time Frame: 8 weeks
|
Change of Medical Research Council Scale results from baseline to 8 weeks.
The Medical Research Council Scale (MRCS) is a five-item scale based on various physical activities that produce dyspnea.
Here, patients are asked to mark the level of activity that causes dyspnea in themselves.
On the scale, 0 describes the best 4 dyspnea and the worst.
|
8 weeks
|
Muscle strength
Time Frame: 8 weeks
|
A hand-held dynamometer will be used to evaluate muscle strength. Muscle strength will be evaluated in the following muscles, each measurement will be made three times and the average will be taken. M. Quadriceps Femoris, M. Tibialis Anterior, and M. Gastrosoleus |
8 weeks
|
Health Related Quality of Life
Time Frame: 8 weeks
|
Change of Saint George Respiratory Questionnaire Results from baseline to 8 weeks.It is a self-answered questionnaire consisting of three categories, evaluating the symptoms, activities and effects of patients on daily life.
It was developed in order to determine the severity of the disease as more comprehensive and sensitive.
Symptoms examined; cough, sputum, wheezing and shortness of breath.
Physical functions, housework and hobbies are questioned to determine activity status.
The survey consists of 76 questions and is completed in 20 minutes.
0 indicates excellent health and 100 indicates worst healt
|
8 weeks
|
The Leicester Cough Questionnaire (LCQ)
Time Frame: 8 weeks
|
Change of The Leicester Cough Questionnaire (LCQ) Results from baseline to 8 weeks.
The Leicester Cough Questionnaire (LCQ) is a HRQoL questionnaire validated for assessing chronic cough.
It is a 19-item, self-completed questionnaire exploring the impact of cough severity across three domains: physical (eight items), psychological (seven items) and social (four items).
The total severity score ranges from 3 to 21, with a lower score indicating greater impairment of health status due to cough.
|
8 weeks
|
Collaborators and Investigators
Investigators
- Study Director: Gökşen KURAN ASLAN, Istanbul University - Cerrahpasa (IUC)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cerrahpasa University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Sarcoidosis
-
Celularity IncorporatedTerminatedStage 2 Pulmonary Sarcoidosis | Stage 3 Pulmonary SarcoidosisUnited States
-
University Hospital, LilleTerminated
-
Alexandria UniversityCompletedEndobronchial Mucosal Pathology in Pulmonary SarcoidosisEgypt
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedSarcoidosis; Antimycobacterial TherapyUnited States
-
National Jewish HealthAmerican Thoracic SocietyCompletedPulmonary SarcoidosisUnited States
-
Medical University of South CarolinaHoffmann-La RocheTerminated
-
University of Milano BicoccaAgenzia Italiana del FarmacoCompletedPulmonary SarcoidosisItaly
-
Daniel DobererTerminatedPulmonary Hypertension | SarcoidosisAustria
-
Ohio State UniversityThe Cleveland ClinicCompletedSarcoidosisUnited States
-
Ohio State UniversityTerminated
Clinical Trials on Exercise- One-Legged
-
Wageningen UniversityDutch Diabetes Research FoundationCompletedExercise | Muscle | Gene Expression | MyokineNetherlands
-
Rigshospitalet, DenmarkCompletedHealthy | Chronic Obstructive Pulmonary Disease | COPDDenmark
-
Kristian KarstoftActive, not recruitingBlood Coagulation DisorderDenmark
-
Ege UniversityEnrolling by invitation
-
Hacettepe UniversityCompleted
-
Duke UniversityCompleted
-
University of Alabama at BirminghamRecruitingCardiometabolic Risk Factors in Adult Wheelchair UsersUnited States
-
University of ManitobaMitacsWithdrawnLow Back Pain
-
University of British ColumbiaCompletedFasciitis, PlantarCanada
-
State University of New York at BuffaloSuspendedCognitive Impairment | Cardiovascular Abnormalities | Spinal Cord Injuries | Cerebrovascular Disease; SequelaeUnited States